---
category: news
title: "Cellworks Personalized Therapy Biosimulation Study Identifies Novel Biomarkers Predictive of Response in AML Patients"
excerpt: "Cellworks Group, Inc., a world leader in Personalized Medicine in the key therapeutic areas of Oncology and Immunology, today announced results from a clinical study using the Cellworks Biosimulation Platform and Computational Omics Biology Model (CBM) to predict therapy response for individual Acute Myeloid Leukemia (AML) patients were featured in a poster presentation at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition held December 11-14,"
publishedDateTime: 2021-12-14T13:10:00Z
originalUrl: "https://www.tmcnet.com/usubmit/-cellworks-personalized-therapy-biosimulation-study-identifies-novel-biomarkers-/2021/12/14/9510699.htm"
webUrl: "https://www.tmcnet.com/usubmit/-cellworks-personalized-therapy-biosimulation-study-identifies-novel-biomarkers-/2021/12/14/9510699.htm"
type: article

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

secured: "qiJvEJiMB8iQy+rg8Q6BPF/CFXjAYLiHJCw8KN0o0NQpq9Xqxvoe4gK6slcd9oByZoIFb6XpXAvHyQdNtrZvWbvVZh5tFlsRIa40ey/Q2fq5wUFIqbguPXQl7gBeWdqTvKvh0U7ZnezHA02oPaX79kx2zabYozq1JYgwNglmyDiFLsmcrAbquI2hnhCm8aiV1b74BjzKnsZMWZrIUezcNAzsHdsW0T8YhJWsYsT2JfsoRkkFQ9CL/XIpt6dF6fUNCL6lMXOFkIs8DPHjw70dfjEE/fg0jDqPB3BRD8lt4VZYUZJ4Bc27GRy17rnid6+SwGNRSANz6wJjfjjY4ptR8e+Ypk8uh0vfI0OcC/m+Mh4=;/22UhcRdZO+4SV5obfdRKg=="
---

